Physical Performance and Quality of Life in Older Adults: Is There Any Association between Them and Potential Drug Interactions in Polymedicated Octogenarians?

Zoraida Verde, Laura García de Diego, Luis M. Chicharro, Fernando Bandrés, Verónica Velasco, Teresa Mingo and Ana Fernández-Araque
Additional contact information
Zoraida Verde: Department of Biochemistry, Molecular Biology and Physiology, Universidad de Valladolid, Campus Duques de Soria, 42004 Soria, Spain
Laura García de Diego: Department of Nursery, Universidad de Valladolid, Campus Duques de Soria, 42004 Soria, Spain
Luis M. Chicharro: Cátedra Complutense Diagnostic and Innovation, Universidad Complutense, 28040 Madrid, Spain
Fernando Bandrés: Cátedra Complutense Diagnostic and Innovation, Universidad Complutense, 28040 Madrid, Spain
Verónica Velasco: Department of Nursery, Universidad de Valladolid, 47005 Valladolid, Spain
Teresa Mingo: Department of Surgery, Ophthalmology, Otorhinolaryngology and Physiotherapy, Universidad de Valladolid, Campus Duques de Soria, 42004 Soria, Spain
Ana Fernández-Araque: Department of Nursery, Universidad de Valladolid, Campus Duques de Soria, 42004 Soria, Spain

IJERPH, 2019, vol. 16, issue 21, 1-10

Abstract: Older adults are at increased risk of several cytochrome P450 (CYP) drug interactions that can result in drug toxicity, reduced pharmacological effect, and adverse drug reactions. This study aimed to assess the prevalence of potential CYP interactions referring to the most clinically relevant drugs and exploring the relationship between them and quality of life and physical performance in Spanish octogenarians. Institutionalized and community-dwelling octogenarians ( n = 102) treated at three primary care centers, were recruited by a research nurse. Anthropometric measurements, chronic diseases, prescribed drugs, quality of life, physical performance, mobility skills, hand grip strength and cognitive status data were collected. Potential CYP drug-drug interactions (DDIs) were selected referring to the main CYP implicated in their metabolism. The 72.2% of recruited octogenarians presented potentially inappropriate CYP inhibitor-substrate or CYP inductor-substrate combinations. Analyzing the EuroQol Visual Analogue scale (EQ-VAS) results, patients with a potential CYP DDI perceived worse health status than patients without it ( p = 0.004). In addition, patients with a potential CYP DDI presented worse exercise capacity, kinesthetic abilities, or mobility than those who didn’t present a potential interaction ( p = 0.01, p = 0.047, and p = 0.02, respectively). To investigate and control factors associated with loss of muscle strength and poor quality of life, polypharmacy and DDIs could help institutions in the management of physical frailty.

Keywords: cytochromes; drug interactions; octogenarians; polypharmacy; mobility; hand grip strength; ISEK test; quality of life (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.mdpi.com/1660-4601/16/21/4190/pdf (application/pdf)
https://www.mdpi.com/1660-4601/16/21/4190/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:16:y:2019:i:21:p:4190-:d:281547

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().